SCHEMBL31694533

SCHEMBL31694533

FC(F)(F)c1cc(NCc2cn(-c3ccc(Oc4ccccc4)cc3)nn2)cc(-c2cn[nH]c2)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.64
▸ CYP2C19 P33261 1/20 0.64
▸ RXRA P19793 10/20 0.42
▸ GRIN1 Q05586 10/20 0.42
▸ GRIN2B Q13224 10/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ APP P05067 4/20 0.39
▸ KDM1A O60341 2/20 0.36
▸ MAP3K8 P41279 1/20 0.35
▸ CDC7 O00311 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ CHUK O15111 1/20 0.35
▸ DAPK3 O43293 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ CDK1 P06493 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30371204 0.93 CYP3A4 (0.54) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL23611383 0.91 CYP3A4 (0.53) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL30061972 0.88 CYP3A4 (0.48) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL23611357 0.88 CYP3A4 (0.48) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL23611398 0.87 CYP3A4 (0.64) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL21612020 0.82 CYP2C19 (0.73) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL21612049 0.82 CYP3A4 (0.73) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL21612055 0.82 CYP3A4 (0.73) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL23611379 0.80 GRIN1 (0.42) CYP3A4CYP2C19RXRAGRIN1GRIN2B
SCHEMBL21614628 0.79 CYP3A4 (1.00) CYP3A4CYP2C19RXRAGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-B1 PYRIDINE AND PYRIMIDINE DERIVATIVES USEFUL AS PQSR INVERSE AGONISTS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-10-08 — — EP disclosed
Send feedback